HGFAC and adenomyosis: The termination variant detected in Hepatocyte Growth Factor Activator (HGFAC) highlights it as a plausible candidate gene for adenomyosis, given its role in activating HGF, which in turn promotes epithelial–mesenchymal transition (EMT) and drives glandular invagination into the myometrium [33].